Form D · Hedge Fund

Sofinnova BioEquities Enhanced Master Fund, LP

Menlo Park, CA · CIK 0001949475

Offering snapshot reported Oct 9, 2026 · SEC filing

Reported sold
$87.2M
Indefinite offering
Investors reported
26
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 3, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$43.6M$87.2MOct 13, 2022: $1,980,195.00Oct 13, 2022Oct 13, 2023: $8,976,198.00Oct 13, 2023Oct 11, 2024: $35,675,289.00Oct 11, 2024Oct 10, 2025: $41,545,600.00Oct 10, 2025Oct 9, 2026: $87,225,567.00Oct 9, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$41,545,600 → $87,225,567
  • Reported investors25 → 26

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 9, 2026Amendment$87,225,567$45,679,967vs Oct 10, 202526SEC filing
Oct 10, 2025Amendment$41,545,600$5,870,311vs Oct 11, 202425SEC filing
Oct 11, 2024Amendment$35,675,289$26,699,091vs Oct 13, 202317SEC filing
Oct 13, 2023Amendment$8,976,198$6,996,003vs Oct 13, 202211SEC filing
Oct 13, 2022Initial$1,980,195No comparison2SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-461670

Source: Form D, filed Oct 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

SOFINNOVA BIOEQUITIES ENHANCED MASTER FUND, LP

Investment adviser: SOFINNOVA INVESTMENTS, INC.

Gross asset value
$1.19B
Beneficial owners
28
ADV minimum commitment
$3M

Reported in Form ADV on Mar 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CITCO FUND ADMINISTRATION (CAYMAN ISLANDS) LIMITED GRAND CAYMAN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG, LLP SAN FRANCISCO, California, United States
Custodian BNY MELLON TRUST COMPANY (IRELAND) LIMITED DUBLIN, Ireland Related to adviser: No
Custodian CITCO BANK CANADA TORONTO, Canada Related to adviser: No
Custodian EQUINITI TRUST COMPANY, LLC NEWARK, New Jersey, United States Related to adviser: No
Custodian GOLDMAN SACHS & CO. LLC SAN FRANCISCO, California, United States Related to adviser: No
Custodian GOLDMAN SACHS INTERNATIONAL LONDON, United Kingdom Related to adviser: No
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Prime broker GOLDMAN SACHS & CO. LLC SAN FRANCISCO, California, United States
Prime broker JEFFERIES LLC SAN FRANCISCO, California, United States
Prime broker J.P. MORGAN SECURITIES INC. SAN FRANCISCO, California, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG, LLP
PCAOB 185

EQUINITI TRUST COMPANY, LLC
LEI 213800YI5RL9BRL4V892

GOLDMAN SACHS & CO. LLC
SEC 8-129

JEFFERIES LLC
SEC 8-15074

J.P. MORGAN SECURITIES LLC
SEC 8-35008

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

JEFFERIES LLC
CRD 2347 · SEC 8-15074

J.P. MORGAN SECURITIES INC.
CRD 18718 · SEC 8-36950

Filing source

Form ADV 2075659 · Mar 27, 2026 · Schedule D 7.B.(1), fund 805-6350579768

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sofinnova Bio Equities Gp Llc Executive, Promoter
Sofinnova Investments, Inc. Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
3000 Sand Hill Road Building 3, Suite 150
Menlo Park, CA, 94025